Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post-Traumatic Stress Disorder

Asad Ullah Jan

Status: Active, not recruiting

Conditions: PTSD - Post Traumatic Stress Disorder

Treatments: Drug: SSRIs; Behavioral: EMDR

Study type: Interventional

Funder types: Other

Identifiers

NCT06957210

CMHNSR-REF-15

Details and patient eligibility

About

This randomized controlled trial investigates the comparative effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy and selective serotonin reuptake inhibitors (SSRIs) in fostering post-traumatic growth among patients diagnosed with post-traumatic stress disorder (PTSD). Participants will be randomized to receive either EMDR therapy or standard SSRI pharmacotherapy. The primary objective is to evaluate the extent of psychological growth and recovery achieved through each intervention, aiming to guide future therapeutic strategies for PTSD.

Enrollment: 130 patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Clinical diagnosis of Post-Traumatic Stress Disorder (PTSD) based on DSM-5 criteria

Willingness to participate and provide informed consent

Ability to comply with study procedures

Exclusion criteria

Current diagnosis of psychotic disorder, bipolar disorder, or severe major depressive episode with psychotic features

Active substance use disorder within the past 6 months

Severe cognitive impairment or inability to complete study assessments

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

130 participants in 2 patient groups

EMDR

Experimental group

Description:

EMDR therapy

Treatment:

Behavioral: EMDR

SSRIs

Active Comparator group

Description:

Acting as control group

Treatment:

Drug: SSRIs